North American Biocompatibility Summit (NABS) 2025

Eurofins EAG Laboratories is proud to be the presenting sponsor for the North American Biocompatibility Summit (NABS) at Quincy Hall in Minneapolis, Minnesota.

Casey Chamberlain, Ph.D., Manager at EAG Laboratories, will present “Collection and Interpretation of Medical Device Extractables Data in the Modern Era.”

Abstract: Proper collection and interpretation of extractable data are critical to ensure the output of a chemical characterization study accurately reflects the potential patient exposome resulting from a medical device. However, due to lack of defined expectation from both regulatory bodies and ISO 10993-18 regarding data handling, there is currently a spectrum of approaches that exists throughout the industry, many of which are insufficient to adequately capture the extractable profile. In this presentation, we will cover three pillars of state-of-the-art chemical characterization data analysis: data deconvolution, high-resolution mass spectrometry, and reference material databases. Each of these items will be discussed with respect to the essential information they provide, along with the chemical insights which are lost in an analytical platform lacking these tools.

Visit the link below to see the NABS schedule or contact us to learn more about medical device testing solutions.

We hope to see you there!